Improving cognitive function in older adults after stem cell transplant
Official title: Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Transplantation
Run by University of Nebraska · NCT04898790 · Data updated 2026-11-12
This study is testing if a special exercise program can help older adults who had a stem cell transplant think better and improve their brain health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 114 (estimated) |
| Sponsor | University of Nebraska Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Omaha, Nebraska) |
| Status | Recruiting |
| Started | November 18, 2021 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT04898790 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 60 years and older who have been diagnosed with a hematological malignancy and have received a stem cell transplant within the past 3-6 months.
✕Probably not a fit
Patients who are younger than 60 years or have not undergone a stem cell transplant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance cognitive function in older adults who have undergone hematopoietic cell transplantation (HCT) for hematological malignancies. It will adapt and test the Community Health Activities Model Program for Seniors II (CHAMPS II), an evidence-based physical activity intervention, specifically for adults aged 60 and older in the HCT setting. The study will involve semi-structured interviews with patients to assess their experiences and needs related to cognitive health. By increasing physical activity, the study hypothesizes that cognitive function can be improved in this vulnerable population, addressing a significant gap in post-transplant care.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cognitive function and quality of life for older adults recovering from stem cell transplants.
How similar studies have gone: While similar interventions have shown success in improving cognitive function in other cancer populations, this specific approach in older adults undergoing HCT is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Arm 1: Inclusion Criteria for Participants: * age 60 years and older * have a diagnosis of hematological malignancy * have received autologous or allogeneic HCT within the prior 3-6 months * able to speak and read English * have provided written informed consent Exclusion Criteria for Participants: * there are no exclusion criteria Inclusion Criteria for Participants' Care-Partner: * age 19 years and older * able to speak and read English Exclusion Criteria for Participants' Care-Partner: * there are no exclusion criteria Inclusion Criteria for Transplant Team Member: * age 19 years and older * able to speak and read English Exclusion Criteria for Transplant Team Member: * there are no exclusion criteria Arms 2 and 3: Inclusion Criteria for Participants: * age 55 years and older * have a diagnosis of hematological malignancy * planned to receive an autologous or allogeneic HCT * able to walk 4 meters as part of the Short Physical Performance Battery (with or without assistance) * (In Arm 3 only): willingness to be randomized to either initiate the physical activity intervention pre-HCT or following Day 180 post-HCT, and to follow the protocol for the group to which they have been assigned * able to speak and read English * have provided written informed consent Exclusion Criteria for Participants: * development of chest pain, severe shortness of breath, or occurrence of other safety concerns during the physical performance measures (i.e. Short Physical Performance Battery) * is not cleared to participate in exercise by a physician Individuals with the following current conditions/diagnoses documented in medical history will be required to provide clearance for exercise from their cardiologist: * Myocardial infarctions in the past 3 months * Resting or unstable angina * Uncontrolled and/or serious arrhythmias * 3rd degree heart block * Acute congestive heart failure or ejection fraction \<30% * Clinically significant aortic stenosis Individuals with the following conditions/diagnoses will be required to provide clearance for exercise from their surgeon: * Hip fracture, hip or knee replacement, or spinal surgery in the past 3 months * other medical, psychiatric, or behavioral factors that in the judgement of the principal investigator may interfere with study participation or the ability to follow either the intervention or the active control condition * (In Arm 3 for those who agree to the voluntary measures of blood, saliva and MRI, there are additional exclusions to avoid conditions that may confound study outcomes): * history of residual brain abnormalities from prior severe traumatic brain injury (e.g. encephalomalacia) or other significant abnormalities documented on a recent brain MRI (e.g. brain cancer, large vessel strokes, residual subdural hematoma) * history of major stroke with obvious residual deficits * history of relapsing and remitting Multiple Sclerosis * active moderate to severe psychiatric symptoms due to primary psychiatric disorder Inclusion Criteria for Participants' Care-Partner: * age 19 years and older * able to speak and read English * able to walk 4 meters as part of the Short Physical Performance Battery (with or without assistance) * have no medical contraindications for participating in light to moderate-intensity physical activity per PI review of medical history as reported on the care-partner medical history form Exclusion Criteria for Participants' Care-Partner: * development of chest pain, severe shortness of breath, or occurrence of other safety concerns during the physical performance measures (i.e. Short Physical Performance Battery) * is not cleared to participate in exercise by a physician Individuals with the following current conditions/diagnoses documented in medical history will be required to provide clearance for exercise from their cardiologist: * Myocardial infarctions in the past 3 months * Resting or unstable angina * Uncontrolled and/or serious arrhythmias * 3rd degree heart block * Acute congestive heart failure or ejection fraction \<30% * Clinically significant aortic stenosis Individuals with the following conditions/diagnoses will be required to provide clearance for exercise from their surgeon: o Hip fracture, hip or knee replacement, or spinal surgery in the past 3 months * other medical, psychiatric, or behavioral factors that in the judgement of the principal investigator may interfere with study participation or the ability to follow either the intervention or the active control condition Inclusion Criteria for Transplant Team Member: * age 19 years and older * able to speak and read English Exclusion Criteria for Transplant Team Member: * there are no exclusion criteria
Where it's running
-
University of Nebraska Medical Center
Omaha, Nebraska, United States Recruiting
Study contacts
- Principal investigator: Thuy Koll, MD — University of Nebraska
- Study coordinator: Marcia M Free, BSN
- Email: marcia.free@unmc.edu
- Phone: 402-559-8151
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau
This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.
-
Improving outcomes for stem cell transplant patients using an intervention website
This study is testing if a special website can help adults with blood cancer feel better and improve their quality of life after a stem cell transplant compared to a regular educational website.
-
Using a NEWS early warning score to prompt ICU admission for adults receiving intensive chemotherapy or stem cell transplant
This trial tests whether real-time monitoring with the NEWS early warning score and prompt ICU admission (NEWS ≥ 7) helps adults with leukemia, lymphoma, or multiple myeloma who are receiving intensive chemotherapy or a hematopoietic cell transplant.
-
Using Darzalex Faspro to lower antibody levels before stem cell transplant
This study is testing if a new treatment called Darzalex Faspro can help lower harmful antibodies in adults so they can safely receive a stem cell transplant for blood cancers.
-
Evaluating a decision support tool for patients with blood cancers
This study tests a new tool called PRIME to see if it helps older adults with blood cancers make treatment choices that better match their personal preferences compared to regular care.
-
Return to Work After Hematologic Cancer
This study tests whether a dedicated return-to-work consultation helps adults with blood cancers who finished treatment to go back to their jobs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.